Company news
Bio-Thera Solutions, Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
March 8, 2023
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8010, an Antibody Drug Conjugate Targeting HER2 for the Treatment of Advanced Solid Tumors
March 6, 2023
China NMPA Approves Bio-Thera Solutions' BAT1806, A Biosimilar to Actemra
January 17, 2023